The Iowa legislature put forward a number of bills concerning healthcare price and competition in the 2018 legislative session. The legislature’s attempts at drug price transparency failed (SF 2026 and SSB 3161). Of the bills that were passed, Governor Reynolds signed a bill to provide telehealth coverage, but vetoed SF 2316, which would have expanded individuals eligible for small-group health coverage in the state. The governor’s actions could boost association health plans (AHPs) in Iowa, which the state plans to launch in 2019.
In the 2017 legislative term, Iowa was relatively inactive in regard to healthcare price transparency, cost, and competition legislation. The state approved a bill that corrects an apparent oversight that has allowed lawmakers to avoid paying hundreds of thousands of dollars each year in health insurance premiums. However, Iowa did not pass legislation concerning constituent healthcare price transparency, cost, and competition.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates.
LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.
Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.
LEGISLATIVE CALENDARIowa’s current legislative session runs from 1/14/2019 – 5/4/2019. Bills from 2019 will carry over to 2020 as part of the 2019-2020 legislative term.
FY 2020-2021 BUDGETIowa’s fiscal year begins July 1st and ends June 30th of the following year. To view Iowa’s 2020-2021 Budget Report, click here.
REGULATION & ENFORCEMENT
- Iowa was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.